Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics of long-acting β2-agonists.

Expert opinion on drug metabolism & toxicology - 1 Jan 2015

Blake Kathryn, Lima John

Abstract excerpt

INTRODUCTION: Long-acting β2-agonists are an effective class of drugs, when combined with inhaled corticosteroids, for reducing symptoms and exacerbations in patients with asthma that is not adequately controlled by inhaled corticosteroids alone. However, because this class of drugs has been associated with severe adverse events, including hospitalization and death in small numbers of patients, efforts to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenergic beta-2 Receptor Agonists
Share to Anti-Asthmatic Agents
Share to Asthma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Delayed-Action Preparations

Share to Genotype

Share to Pharmacogenetics

Share to Receptors, Adrenergic, beta-2

Source

Identifiers

PMID: 26235677
DOI: 10.1517/17425255.2015.1071793

Genes

ADRB2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics of long-acting β2-agonists.PMID 26235677Read ↗

Pharmacogenetics of β2-AgonistsSemantic proximity Read ↗

Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study.Semantic proximity Read ↗

Clinical consequences of ADRbeta2 polymorphisms.Semantic proximity Read ↗

Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.Semantic proximity Read ↗

Treatment response heterogeneity in asthma: the role of genetic variation.Semantic proximity Read ↗

Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthmaSemantic proximity Read ↗

Pharmacogenetics of asthma.Semantic proximity Read ↗

Do genetic polymorphisms alter patient response to inhaled bronchodilators?Semantic proximity Read ↗

Beta2-adrenoceptor polymorphisms and obstructive airway diseases: important issues of study design.Semantic proximity Read ↗

Arg16 ADRB2 genotype increases the risk of asthma exacerbation in children with a reported use of long-acting β2-agonists: results of the PACMAN cohort.Semantic proximity Read ↗

Development and Validation of Real-Time Allele-Specific PCR-Based Genotyping of the rs1042713 Variant in the ADRB2 Gene and Its Correlation with Salbutamol Response.Semantic proximity Read ↗

Childhood asthma exacerbations and the Arg16 β2-receptor polymorphism: A meta-analysis stratified by treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.